Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

An Epstein-Barr Virus Mutant Produces Immunogenic Defective Particles Devoid of Viral DNA

13 Dec 2012

Abstract excerpt

Virus-like particles (VLPs) from hepatitis B and human papillomaviruses have been successfully used as preventative vaccines against these infectious agents. These VLPs consist of a self-associating capsid polymer formed from a single structure protein and are devoid of viral DNA. Since virions from herpesviruses consist of a large number of molecules of viral and cellular origin, generating VLPs from a subset of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cytomegalovirus and herpesvirus research
Share to Herpesvirus Infections and Treatments
Share to Viral-associated cancers and disorders

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 23236073
DOI: 10.1128/jvi.02533-12

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

An Epstein-Barr Virus Mutant Produces Immunogenic Defective Particles Devoid of Viral DNAPMID 23236073Read ↗

A Virus-Like Particle-Based Epstein-Barr Virus VaccineSemantic proximity Read ↗

Epstein-Barr Virus BKRF4 Gene Product Is Required for Efficient Progeny Production.Semantic proximity Read ↗

Immunogenic particles with a broad antigenic spectrum stimulate cytolytic T cells and offer increased protection against EBV infection ex vivo and in miceSemantic proximity Read ↗

The Epstein-Barr Virus Major Tegument Protein BNRF1 Is a Common Target of Cytotoxic CD4+T CellsSemantic proximity Read ↗

Primary B-cell infection with a deltaBALF4 Epstein-Barr virus comes to a halt in the endosomal compartment yet still elicits a potent CD4-positive cytotoxic T-cell response.Semantic proximity Read ↗

The Epstein-Barr virus alkaline exonuclease BGLF5 serves pleiotropic functions in virus replication.Semantic proximity Read ↗

Systematic analysis of Epstein-Barr virus genes and their individual contribution to virus production and compositionSemantic proximity Read ↗

Self-Assembly of Epstein-Barr Virus CapsidsSemantic proximity Read ↗

Epstein-Barr virus BNRF1 protein allows efficient transfer from the endosomal compartment to the nucleus of primary B lymphocytes.Semantic proximity Read ↗

A first-generation packaging cell line for Epstein–Barr virus-derived vectorsSemantic proximity Read ↗

The<i>BFRF1</i>Gene of Epstein-Barr Virus Encodes a Novel ProteinSemantic proximity Read ↗

The Epstein-Barr virus lytic program is controlled by the co-operative functions of two transactivators.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.